S Sajith Kumar (Sajith Kumar S, Sajith Kumar)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Systematic Review

Cervical Cancer Screening

Systemic Sclerosis

Top Venues

Expert review of pharmacoeconomics & outcomes research

ClinicoEconomics and outcomes research : CEOR

BMJ open gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Bhavani Shankara Bagepally, S Sajith Kumar, Akhil Sasidharan
Evaluating Health Expenditure Trends and Disease Burden in India: A Cost per DALY Approach. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Bhavani Shankara Bagepally, S Sajith Kumar, Akhil Sasidharan
Evaluating Health Expenditure Trends and Disease Burden in India: A Cost per DALY Approach. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Roopa Hariprasad, Bhavani Shankara Bagepally, S Sajith Kumar, Sangeeta Pradhan, Deepsikka Gurung, Harki Tamang, Arpana Sharma, Tarun Bhatnagar
Cost-utility analysis of primary HPV testing through home-based self-sampling in comparison to visual inspection using acetic acid for cervical cancer screening in East district, Sikkim, India, 2023. PloS one 19 (8) (2024)
Roopa Hariprasad, Bhavani Shankara Bagepally, S Sajith Kumar, Sangeeta Pradhan, Deepsikka Gurung, Harki Tamang, Arpana Sharma, Tarun Bhatnagar
Cost-utility analysis of primary HPV testing through home-based self-sampling in comparison to visual inspection using acetic acid for cervical cancer screening in East district, Sikkim, India, 2023. PloS one 19 (8) (2024)
S Sajith Kumar, Bhavani Shankara Bagepally
Cost-effectiveness of tumor necrosis factor-alpha inhibitors: a systematic review and meta-analysis of cost-utility studies. Expert review of pharmacoeconomics & outcomes research (2023)
Madhumitha Haridoss, S Sajith Kumar, Meenakumari Natarajan, Akhil Sasidharan, Kavitha Rajsekar, Nikhil Kumar Oswal, Bhavani Shankara Bagepally
Cost-effectiveness of cholecystectomy compared to conservative management in people presenting with uncomplicated symptomatic gallstones or cholecystitis in India. Expert review of pharmacoeconomics & outcomes research (2022)
Bhavani Shankara Bagepally, S Sajith Kumar, Meenakumari Natarajan, Akhil Sasidharan
Incremental net benefit of cholecystectomy compared with alternative treatments in people with gallstones or cholecystitis: a systematic review and meta-analysis of cost-utility studies. BMJ open gastroenterology 9 (1) (2022)
Madhumitha Haridoss, S Sajith Kumar, Meenakumari Natarajan, Akhil Sasidharan, Kavitha Rajsekar, Nikhil Kumar Oswal, Bhavani Shankara Bagepally
Cost-effectiveness of cholecystectomy compared to conservative management in people presenting with uncomplicated symptomatic gallstones or cholecystitis in India. Expert review of pharmacoeconomics & outcomes research (2022)
Akhil Sasidharan, Bhavani Shankara Bagepally, S Sajith Kumar, Kayala Venkata Jagadeesh, Meenakumari Natarajan
Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies. PloS one 17 (6) (2022)
Madhumitha Haridoss, S Sajith Kumar, Meenakumari Natarajan, Akhil Sasidharan, Kavitha Rajsekar, Nikhil Kumar Oswal, Bhavani Shankara Bagepally
Cost-effectiveness of cholecystectomy compared to conservative management in people presenting with uncomplicated symptomatic gallstones or cholecystitis in India. Expert review of pharmacoeconomics & outcomes research 23 (2) (2022)
Madhumitha Haridoss, S Sajith Kumar, Meenakumari Natarajan, Akhil Sasidharan, Kavitha Rajsekar, Nikhil Kumar Oswal, Bhavani Shankara Bagepally
Cost-effectiveness of cholecystectomy compared to conservative management in people presenting with uncomplicated symptomatic gallstones or cholecystitis in India. Expert review of pharmacoeconomics & outcomes research 23 (2) (2022)